4//SEC Filing
Lung Therapeutics, Inc. 4
Accession 0001213900-21-018561
CIK 0001733413other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 11:43 AM ET
Size
4.6 KB
Accession
0001213900-21-018561
Insider Transaction Report
Form 4
Lung Therapeutics, Inc.
10% Owner
Transactions
- Sale
Common Stock
2021-03-26$14.00/sh−715,000$10,010,000→ 2,235,000 total
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001611241
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 11:43 AM ET
- Size
- 4.6 KB